Eating Disorders

Comprehensive tutorial on eating disorders including anorexia nervosa, bulimia nervosa, and binge-eating disorder. DSM-5 diagnostic criteria, medical complications, epidemiology, neurobiology, and evidence-based treatment approaches.

This content is for informational purposes only. Always consult a healthcare professional.

Eating disorders are serious mental illnesses characterized by persistent disturbances in eating or eating-related behaviors that significantly impair physical health and psychosocial functioning. They have the highest mortality rate of any mental disorder.

Overview of Eating Disorders

Disorder Core Feature Weight Status Binge Eating Compensatory Behaviors
Anorexia nervosa (AN) Restriction of energy intake relative to requirements Significantly low body weight Possible (binge-purge subtype) Purging or other behaviors (in binge-purge subtype)
Bulimia nervosa (BN) Recurrent binge eating + compensatory behaviors Normal or overweight Yes Yes (vomiting, laxatives, fasting, excessive exercise)
Binge-eating disorder (BED) Recurrent binge eating without compensatory behaviors Overweight or obesity Yes No
Avoidant/restrictive food intake disorder (ARFID) Restrictive eating without body image disturbance Often low weight No No
Other specified feeding/eating disorder (OSFED) Atypical presentations Variable Variable Variable

Anorexia Nervosa (AN)

Anorexia nervosa is characterized by restriction of energy intake relative to requirements, leading to significantly low body weight, intense fear of weight gain, and disturbance in the experience of body weight and shape.

DSM-5 Diagnostic Criteria

Criterion Description
A. Restriction Restriction of energy intake relative to requirements, leading to significantly low body weight (less than minimally normal/expected)
B. Fear of weight gain Intense fear of gaining weight or becoming fat, or persistent behavior that interferes with weight gain
C. Body image disturbance Disturbance in how body weight/shape is experienced; undue influence on self-evaluation; lack of recognition of seriousness of low body weight

Specifiers:

Subtypes:

Subtype Description
Restricting type During last 3 months, weight loss主要通过 dieting, fasting, and/or excessive exercise; no binge eating or purging
Binge-eating/purging type During last 3 months, has engaged in recurrent binge eating or purging behaviors (self-induced vomiting, laxatives, diuretics)

Severity (based on BMI):

Level BMI (adults)
Mild ≥ 17.0
Moderate 16.0-16.99
Severe 15.0-15.99
Extreme < 15.0

Epidemiology

Metric Value
Lifetime prevalence ~0.5-2%
Female:male ratio ~10:1
Mean age of onset ~15-19 years
Standardized mortality ratio (SMR) ~5-6 (highest of any mental disorder)
Suicide rate Elevated (second leading cause of death in AN)
Recovery rate (over 10 years) ~50-70%
Chronic course ~20%

Medical Complications

System Complications
Cardiovascular Bradycardia, hypotension, prolonged QTc, arrhythmias, mitral valve prolapse, cardiomyopathy (refeeding)
Endocrine Hypothalamic amenorrhea, low T3 syndrome, growth hormone resistance, osteoporosis, stress fractures
Gastrointestinal Delayed gastric emptying, constipation, superior mesenteric artery syndrome, pancreatitis
Renal Dehydration, electrolyte abnormalities, pre-renal azotemia, nephrolithiasis
Hematologic Leukopenia, anemia, thrombocytopenia
Integumentary Lanugo, dry skin, acrocyanosis, hair thinning, Russell sign (from purging)
Neurologic Generalized brain atrophy (reversible with weight restoration), peripheral neuropathy
Metabolic Hypokalemia, hypophosphatemia (refeeding syndrome), hypomagnesemia

Refeeding syndrome:

  • Potentially fatal metabolic disturbance when nutrition is reintroduced too rapidly
  • Characterized by hypophosphatemia, hypokalemia, hypomagnesemia
  • Can cause cardiac arrhythmias, respiratory failure, delirium, death
  • Prevention: Slow refeeding, monitoring electrolytes, phosphate supplementation

Medical Monitoring

Parameter Frequency
Weight, vital signs (orthostatic) Weekly initially, then as indicated
Electrolytes (K, Na, Cl, CO2) Weekly until stable, then as indicated
Phosphate, magnesium Especially during refeeding (daily initially)
ECG Baseline; repeat with electrolyte abnormalities
Bone density (DXA) If amenorrhea > 6-12 months
Cardiac monitoring With significant bradycardia or arrhythmias

Bulimia Nervosa (BN)

Bulimia nervosa is characterized by recurrent episodes of binge eating followed by inappropriate compensatory behaviors to prevent weight gain.

DSM-5 Diagnostic Criteria

Criterion Description
A. Binge eating Recurrent episodes of binge eating, characterized by both: (1) eating a large amount of food in a discrete period (2 hours) and (2) sense of lack of control
B. Compensatory behaviors Recurrent inappropriate compensatory behaviors to prevent weight gain (purging, laxatives, fasting, excessive exercise)
C. Frequency Binge eating and compensatory behaviors both occur at least once weekly for 3 months
D. Self-evaluation Self-evaluation unduly influenced by body weight and shape
E. Exclusion Not occurring exclusively during anorexia nervosa

Severity (based on compensatory behaviors per week):

Level Frequency
Mild 1-3 episodes
Moderate 4-7 episodes
Severe 8-13 episodes
Extreme 14+ episodes

Epidemiology

Metric Value
Lifetime prevalence ~1-2%
Female:male ratio ~8-10:1
Mean age of onset ~18-20 years
Usually normal weight or overweight BMI typically in 18.5-30 range
Course Chronic without treatment; waxing/waning

Medical Complications of Purging Behaviors

Behavior Complications
Self-induced vomiting Dental erosion (perimylolysis), parotid enlargement, esophageal tears (Mallory-Weiss), aspiration, calluses on hands (Russell sign), metabolic alkalosis, hypokalemia
Laxative abuse Electrolyte disturbances, cathartic colon, dependence
Diuretic abuse Electrolyte disturbances, dehydration
Excessive exercise Overuse injuries, stress fractures, cardiac strain

Binge-Eating Disorder (BED)

Binge-eating disorder is characterized by recurrent episodes of binge eating without the regular use of compensatory behaviors.

DSM-5 Diagnostic Criteria

Criterion Description
A. Binge eating Recurrent episodes of binge eating with lack of control
B. Binge characteristics (3+ of 5) (1) Eating more rapidly than normal; (2) Eating until uncomfortably full; (3) Eating large amounts when not hungry; (4) Eating alone due to embarrassment; (5) Feeling disgusted, depressed, or guilty after
C. Marked distress Marked distress regarding binge eating
D. Frequency At least once weekly for 3 months
E. Exclusion Not associated with regular compensatory behaviors; not during AN or BN

Severity (based on binge episodes per week):

Level Frequency
Mild 1-3 episodes
Moderate 4-7 episodes
Severe 8-13 episodes
Extreme 14+ episodes

Epidemiology

Metric Value
Lifetime prevalence ~2-3%
Female:male ratio ~2:1 (more even than AN/BN)
Mean age of onset ~22-25 years
Associated with obesity ~50-70% of BED patients have BMI > 30
Course Often chronic without treatment

Medical Complications

System Complications
Metabolic Obesity-related: insulin resistance, type 2 diabetes, metabolic syndrome, dyslipidemia, hypertension
Cardiovascular Cardiovascular disease (associated with obesity)
Gastrointestinal GERD, IBS, gallbladder disease
Musculoskeletal Osteoarthritis (weight-bearing joints)
Sleep Obstructive sleep apnea
Psychological High rates of depression, anxiety, low quality of life

Other Specified Feeding or Eating Disorder (OSFED)

Presentation Description
Atypical anorexia All criteria for AN met except weight is not low (despite significant weight loss)
Bulimia nervosa (low frequency/limited duration) BN criteria met but behaviors at lower frequency or duration
Binge-eating disorder (low frequency/limited duration) BED criteria met but at lower frequency or duration
Purging disorder Purging without binge eating
Night eating syndrome Excessive evening/nighttime eating, with awareness and recall

Avoidant/Restrictive Food Intake Disorder (ARFID)

ARFID is characterized by restriction of food intake leading to nutritional deficiencies, weight loss, or psychosocial impairment, but without body image disturbance.

Feature Description
Eating patterns Limited food intake based on sensory sensitivity (texture, taste, smell), fear of aversive consequences (choking, vomiting), or lack of interest in food
Body image No fear of weight gain or body image disturbance
Onset Often childhood (but can persist into adulthood)
Comorbidity Autism spectrum disorder, ADHD, anxiety disorders, OCD
Treatment Exposure therapy, nutrition counseling, family-based treatment (children)

Risk Factors

Biological

Factor AN BN BED
Heritability ~50-60% ~40-60% ~40-50%
Twin concordance (MZ) ~50% ~35% ~30%
Specific genetic loci AN GWAS significant Limited Limited
Premorbid BMI Lower Higher Higher

Psychological

Domain Risk Factors
Personality Perfectionism (especially AN), neuroticism, harm avoidance (AN), novelty seeking (BN), negative urgency
Cognitive Body dissatisfaction, thin-ideal internalization, low self-esteem, cognitive rigidity
Temperament Behavioral inhibition, negative affectivity, emotional dysregulation
Dieting Early dieting is a strong predictor of onset

Environmental

Domain Risk Factors
Family Family history of eating disorders, parental eating/weight concerns, family dysfunction
Peer Peer weight pressures, weight-related teasing/bullying
Cultural Western beauty ideals, thinness pressure, social media, weight-based discrimination
Trauma Childhood sexual abuse (especially BN, BED), physical abuse, neglect
Occupational/athletic Ballet, gymnastics, wrestling, modeling (weight-sensitive industries)

Treatment

Anorexia Nervosa

Intervention Description Evidence
Nutritional rehabilitation Weight restoration (0.5-1 kg/week inpatient; 0.25-0.5 kg/week outpatient); monitored refeeding Essential for medical stabilization
Family-based treatment (FBT) For adolescents; parents manage refeeding; three phases First-line for adolescents
Enhanced CBT (CBT-E) Adapted for AN; focuses on eating behaviors, weight, and maintaining mechanisms Moderate evidence
Adolescent-focused therapy (AFT) Individual therapy for adolescents with AN Moderate evidence
Maudsley Anorexia Nervosa Treatment for Adults (MANTRA) Specific to adult AN; motivational + cognitive remediation Moderate evidence
Supportive clinical management Medical monitoring, education, support Moderate evidence
Olanzapine Atypical antipsychotic for weight gain, anxiety Limited evidence; sometimes used adjunctively

Levels of care:

Level Criteria
Medical hospitalization Medical instability (HR < 40, BP < 90/60, orthostatic changes, electrolyte disturbances, < 75% IBW, rapid decline)
Residential Medically stable but needs 24-hour support for refeeding and therapy
Partial hospitalization Needs daily structured programming but can sleep at home
Intensive outpatient Needs multiple sessions per week
Outpatient Medically stable, motivated, good support system

Bulimia Nervosa

Intervention Description Evidence
CBT-E (enhanced) Addresses binge eating, compensatory behaviors, overvaluation of shape/weight Strong; first-line for adults
Interpersonal psychotherapy (IPT) Focus on interpersonal problems maintaining disorder Moderate; alternative to CBT
Dialectical behavior therapy (DBT) Emotion regulation, distress tolerance Moderate
Fluoxetine (SSRI) High-dose fluoxetine (60 mg/day); reduces binge-purge frequency Strong; FDA-approved
Topiramate Anticonvulsant; reduces binge-purge frequency Moderate; side effect profile limits use
Guided self-help CBT Structured workbook with minimal therapist contact Moderate; for less severe cases

Binge-Eating Disorder

Intervention Description Evidence
CBT-E Same protocol as BN; addresses binge eating Strong; first-line
IPT Focuses on interpersonal triggers Strong; comparable to CBT
DBT Intercepts binge episodes; distress tolerance Moderate
Lisdexamfetamine Stimulant prodrug; reduces binge episodes Strong; FDA-approved
SSRIs Moderate reduction in binge eating Moderate
Topiramate Significant reduction in binge eating Moderate; side effects
Weight loss treatment Behavioral weight loss + CBT For BED with obesity

Special Populations

Children and Adolescents

  • Family-based treatment (FBT) is first-line for adolescent AN
  • Early intervention improves outcomes
  • Medical complications more rapid in younger patients due to lower body reserves
  • Growth and development monitoring essential

Males

  • Underdiagnosed and undertreated
  • May present with muscle dysmorphia (pursuit of muscularity rather than thinness)
  • Higher rates of binge eating compared to AN/BN
  • Greater stigma in seeking help

Athletes

  • High-risk populations: endurance sports, aesthetic sports (gymnastics, figure skating), weight-class sports (wrestling, rowing)
  • Female athlete triad: Disordered eating, amenorrhea, osteoporosis
  • Relative energy deficiency in sport (RED-S)

Prognosis and Recovery

Outcome AN BN BED
Full recovery (long-term) ~50-60% ~50-70% ~60-70%
Partial recovery ~20-30% ~20-30% ~20%
Chronic course ~15-20% ~10-20% ~10-20%
Mortality ~5-10% (highest psychiatric mortality) ~2-3% ~1-2%
Relapse rate ~30-50% ~30-40% ~30-40%
Recovery predictors Early intervention, shorter illness duration, less severe weight loss Motivation, early symptom reduction, psychosocial stability Treatment adherence, social support

References

  1. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). Arlington, VA: APA.
  2. Treasure, J., et al. (2020). Eating disorders. Lancet, 395(10227), 899-911.
  3. Zipfel, S., et al. (2015). Anorexia nervosa. Nature Reviews Disease Primers, 1, 15074.
  4. National Institute of Mental Health. (2023). Eating Disorders. NIMH.
  5. Taylor, C. B., et al. (2020). Bulimia nervosa. New England Journal of Medicine, 382(5), 464-473.
  6. Yager, J., et al. (2014). Practice guideline for the treatment of patients with eating disorders (3rd ed.). American Journal of Psychiatry, 171(7), 798-799.
  7. Lock, J., & Le Grange, D. (2015). Treatment Manual for Anorexia Nervosa (2nd ed.). Guilford Press.
  8. National Eating Disorders Association. (2023). Statistics and Research on Eating Disorders. NEDA.